Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China

Autor: Changwen Ke, Chris Ka Pun Mok, Wenfei Zhu, Haibo Zhou, Jianfeng He, Wenda Guan, Jie Wu, Wenjun Song, Dayan Wang, Jiexiong Liu, Qinhan Lin, Daniel Ka Wing Chu, Lei Yang, Nanshan Zhong, Zifeng Yang, Yuelong Shu, Joseph Sriyal Malik Peiris

Publikováno v: Emerging Infectious Diseases, Vol 23, Iss 8, Pp 1332-1340 (2017)

The recent increase in zoonotic avian influenza A(H7N9) disease in China is a cause of public health concern. Most of the A(H7N9) viruses previously reported have been of low pathogenicity. We report the fatal case of a patient in China who was infec

Externí odkaz: https://doaj.org/article/72474c10ead744b1bdf98a3df5c8f5c2

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Autor: George R Thompson, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Methee Chayakulkeeree, Ivan Poromanski, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas, Murat Akova, Rawan AlAgha, George Alangaden, Svenja J Albrecht, Barbara Alexander, Mohanad Al-Obaidi, German Ambasch, Fernando Armestar Rodriguez, Alpay Azap, Anthony Baffoe-Bonnie, Leila Belkhir, Ronen Ben-Ami, David Boutoille, Antonio Cascio, Louis YA Chai, Romanee Chaiwarith, Sharon Chen, Yee-Chun Chen, Yen-Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Herve Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortún-Abete, Julia Garcia-Diaz, Massimo Girardis, Fang He, Maya Hites, Mao-Wang Ho, Patrick Honore, Juan Pablo Horcajada Gallego, Haihui Huang, Po-Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jauregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V Kern, Daniel H Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Anastasia Kotanidou, Anne Lachiewicz, Qinhan Lin, Luis Eduardo Lopez Cortes, Hong Luo, Roberto Luzzati, Yasmin Maor, Todd McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean-Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Munoz Garcia de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabasi, Vasileios Papastamopoulos, David Paterson, Thomas F Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaetan J Plantefeve, Ivan G Poromanski, Debra Powell, Mina Psichogiou, Ser Hon Puah, Galia Rahav, Antonio Ramos Martinez, Juan Carlos Ramos Ramos, Ayelet Raz-Pasteur, Carlos A Restrepo Castro, Fernando Riera, France Roblot, Regino Jose Rodriguez Alvarez, Benjamin Rogers, Emmanuel Roilides, Gregorio Sanchez Vallejo, Gabriele Sganga, Nikolaos Sipsas, Monica Slavin, Andrej Spec, Jacob Strahilevitz, Dora M Tancheva, Zhen Tao, Daniel Teschner, Eric Van Wijngaerden, Paschalis Vergidis, Pierluigi Viale, Fu-Der Wang, Shifu Wang, Gabriel Weber, Jianyu Weng, Jinfu Xu, Li Yao, Serap Yavuz, Mesut Yilmaz, Jo-Anne Young, Abel H Zarate, Jun Zeng, Yong Zhang

Publikováno v: Lancet, Vol. 401, no. 10370, p. 49-59 (2023)
The Lancet (London), 401, 49-59
The Lancet (London), 401, 10370, pp. 49-59
Lancet, p. [1-11] (2022)

Item does not contain fulltext BACKGROUND: Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, Aspergi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d232fde8055f33c79f2f4b250c2a2249
https://doi.org/10.1016/S0140-6736(22)02324-8

Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial

Autor: Yongjun Liu, Xiangyou Yu, Duming Zhu, Jun Zeng, Qinhan Lin, Bin Zang, Chuanxi Chen, Ning Liu, Xiao Liu, Wei Gao, Xiangdong Guan

Publikováno v: Chinese medical journal. 135(9)

Ciprofol (HSK3486; Haisco Pharmaceutical Group Co., Ltd., Chengdu, China), developed as a novel 2,6-disubstituted phenol derivative showed similar tolerability and efficacy characteristics as propofol when applicated as continuous intravenous infusio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d25d95b12118521da4a899949fa07b
https://pubmed.ncbi.nlm.nih.gov/34924506